| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | RHCG ATP7A ABCA13 SPNS2 TMC6 SLC22A15 SLC44A2 SPNS3 ATP9A CALHM4 ITPR1 CLPTM1L ABCG1 ATP6V0A4 PITPNM3 PEX2 ATP12A SLC14A2 SLC4A5 | 1.39e-05 | 1289 | 98 | 19 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | RHCG ATP7A ABCA13 SPNS2 TMC6 SLC22A15 SLC44A2 SPNS3 CALHM4 ITPR1 ABCG1 ATP6V0A4 PEX2 ATP12A SLC14A2 SLC4A5 | 1.93e-04 | 1180 | 98 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.01e-04 | 109 | 98 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 4.12e-04 | 196 | 98 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 7.28e-04 | 36 | 98 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 7.28e-04 | 36 | 98 | 3 | GO:0015662 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | SMG1 OGT SPNS2 CDS2 ACSM1 SLC44A2 MTMR1 ST8SIA1 KAT2B ABCG1 FAR2 ORMDL2 SCD MTM1 NUS1 CERS3 PITPNM3 PEX2 | 6.42e-08 | 813 | 100 | 18 | GO:0008610 |
| Domain | Rhs_assc_core | 8.48e-05 | 3 | 100 | 2 | IPR022385 | |
| Domain | ARM-type_fold | 8.58e-05 | 339 | 100 | 9 | IPR016024 | |
| Domain | Tox-GHH_dom | 1.69e-04 | 4 | 100 | 2 | IPR028916 | |
| Domain | Ten_N | 1.69e-04 | 4 | 100 | 2 | IPR009471 | |
| Domain | Ten_N | 1.69e-04 | 4 | 100 | 2 | PF06484 | |
| Domain | TENEURIN_N | 1.69e-04 | 4 | 100 | 2 | PS51361 | |
| Domain | Tox-GHH | 1.69e-04 | 4 | 100 | 2 | PF15636 | |
| Domain | TPR-like_helical_dom | 2.57e-04 | 233 | 100 | 7 | IPR011990 | |
| Domain | FATC | 2.81e-04 | 5 | 100 | 2 | PF02260 | |
| Domain | YD | 2.81e-04 | 5 | 100 | 2 | IPR006530 | |
| Domain | FAT | 4.20e-04 | 6 | 100 | 2 | PS51189 | |
| Domain | FATC | 4.20e-04 | 6 | 100 | 2 | PS51190 | |
| Domain | FATC_dom | 4.20e-04 | 6 | 100 | 2 | IPR003152 | |
| Domain | PIK_FAT | 4.20e-04 | 6 | 100 | 2 | IPR014009 | |
| Domain | FATC | 4.20e-04 | 6 | 100 | 2 | SM01343 | |
| Domain | HRM | 4.43e-04 | 28 | 100 | 3 | PF02793 | |
| Domain | Clathrin | 5.86e-04 | 7 | 100 | 2 | PF00637 | |
| Domain | - | 5.86e-04 | 7 | 100 | 2 | 1.10.3430.10 | |
| Domain | Ammonium/urea_transptr | 5.86e-04 | 7 | 100 | 2 | IPR029020 | |
| Domain | - | 6.60e-04 | 32 | 100 | 3 | 3.40.1110.10 | |
| Domain | - | 6.60e-04 | 32 | 100 | 3 | 2.70.150.10 | |
| Domain | Clathrin_H-chain/VPS_repeat | 7.78e-04 | 8 | 100 | 2 | IPR000547 | |
| Domain | GPS | 7.90e-04 | 34 | 100 | 3 | SM00303 | |
| Domain | HAD-like_dom | 8.55e-04 | 79 | 100 | 4 | IPR023214 | |
| Domain | GPS | 8.61e-04 | 35 | 100 | 3 | PF01825 | |
| Domain | ATPase_P-typ_cyto_domN | 8.61e-04 | 35 | 100 | 3 | IPR023299 | |
| Domain | - | 8.65e-04 | 207 | 100 | 6 | 1.25.40.10 | |
| Domain | P_typ_ATPase | 9.35e-04 | 36 | 100 | 3 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 9.35e-04 | 36 | 100 | 3 | IPR018303 | |
| Domain | GPS | 9.35e-04 | 36 | 100 | 3 | PS50221 | |
| Domain | ATPASE_E1_E2 | 9.35e-04 | 36 | 100 | 3 | PS00154 | |
| Domain | GPS | 1.01e-03 | 37 | 100 | 3 | IPR000203 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.01e-03 | 37 | 100 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.01e-03 | 37 | 100 | 3 | PF00122 | |
| Domain | LAM_G_DOMAIN | 1.10e-03 | 38 | 100 | 3 | PS50025 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.27e-03 | 40 | 100 | 3 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 1.27e-03 | 40 | 100 | 3 | IPR001879 | |
| Domain | Laminin_G_2 | 1.27e-03 | 40 | 100 | 3 | PF02210 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.27e-03 | 40 | 100 | 3 | PS50227 | |
| Domain | TPR-contain_dom | 1.28e-03 | 150 | 100 | 5 | IPR013026 | |
| Domain | GAIN_dom_N | 1.51e-03 | 11 | 100 | 2 | IPR032471 | |
| Domain | GAIN | 1.51e-03 | 11 | 100 | 2 | PF16489 | |
| Domain | LamG | 1.68e-03 | 44 | 100 | 3 | SM00282 | |
| Domain | NHL | 2.13e-03 | 13 | 100 | 2 | PS51125 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.43e-03 | 50 | 100 | 3 | PS00650 | |
| Domain | 7tm_2 | 2.43e-03 | 50 | 100 | 3 | PF00002 | |
| Domain | Myotubularin-like_Pase_dom | 2.48e-03 | 14 | 100 | 2 | IPR010569 | |
| Domain | PPASE_MYOTUBULARIN | 2.48e-03 | 14 | 100 | 2 | PS51339 | |
| Domain | Myotubularin_fam | 2.48e-03 | 14 | 100 | 2 | IPR030564 | |
| Domain | Myotub-related | 2.48e-03 | 14 | 100 | 2 | PF06602 | |
| Domain | PI3/4_kinase_CS | 2.85e-03 | 15 | 100 | 2 | IPR018936 | |
| Domain | GRAM | 3.24e-03 | 16 | 100 | 2 | SM00568 | |
| Domain | - | 3.24e-03 | 16 | 100 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 3.24e-03 | 16 | 100 | 2 | SM00146 | |
| Domain | CarboxyPept-like_regulatory | 3.66e-03 | 17 | 100 | 2 | IPR008969 | |
| Domain | Laminin_G | 3.71e-03 | 58 | 100 | 3 | IPR001791 | |
| Domain | GPCR_2_secretin-like | 4.09e-03 | 60 | 100 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 4.09e-03 | 60 | 100 | 3 | IPR017981 | |
| Domain | PI3/4_kinase_cat_dom | 4.11e-03 | 18 | 100 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 4.11e-03 | 18 | 100 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 4.11e-03 | 18 | 100 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 4.11e-03 | 18 | 100 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 4.11e-03 | 18 | 100 | 2 | PS00916 | |
| Domain | EGF_CA | 4.19e-03 | 122 | 100 | 4 | SM00179 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.28e-03 | 61 | 100 | 3 | PS50261 | |
| Domain | EGF-like_Ca-bd_dom | 4.44e-03 | 124 | 100 | 4 | IPR001881 | |
| Domain | - | 4.90e-03 | 64 | 100 | 3 | 3.40.50.1000 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | OGT TMC6 CHD3 SESN1 TASOR2 PCNX2 RANBP17 PHKB PCYOX1L ABCG1 PNPLA6 ANKAR SLC4A5 TRAPPC9 AFF4 NLK ADSS1 | 1.75e-06 | 1489 | 103 | 17 | 28611215 |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 23137523 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24861918 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 23707794 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24577890 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 25487306 | ||
| Pubmed | Association of genetic polymorphisms in TERT-CLPTM1L with lung cancer in a Chinese population. | 8.69e-06 | 2 | 103 | 2 | 25966219 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 23226346 | ||
| Pubmed | The TERT-CLPTM1L locus for lung cancer predisposes to bronchial obstruction and emphysema. | 8.69e-06 | 2 | 103 | 2 | 21622582 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 31935503 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 20570912 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 28025427 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 29939218 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 26621837 | ||
| Pubmed | The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. | 8.69e-06 | 2 | 103 | 2 | 20700438 | |
| Pubmed | Polymorphisms of the TERT-CLPTM1L Gene Are Associated with Pharynx-Larynx Cancer. | 8.69e-06 | 2 | 103 | 2 | 31429604 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 25037574 | ||
| Pubmed | Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck. | 8.69e-06 | 2 | 103 | 2 | 20802237 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 26545403 | ||
| Pubmed | Genetic variations in TERT-CLPTM1L genes and risk of lung cancer in Chinese women nonsmokers. | 8.69e-06 | 2 | 103 | 2 | 23738012 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 21332924 | ||
| Pubmed | Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. | 8.69e-06 | 2 | 103 | 2 | 19151717 | |
| Pubmed | Significant association of 5p15.33 (TERT-CLPTM1L genes) with lung cancer in Chinese Han population. | 8.69e-06 | 2 | 103 | 2 | 23368278 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24386361 | ||
| Pubmed | Genetic variations in the TERT and CLPTM1L gene region and gastrointestinal stromal tumors risk. | 8.69e-06 | 2 | 103 | 2 | 26372813 | |
| Pubmed | Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. | 8.69e-06 | 2 | 103 | 2 | 21771723 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 25007268 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 22037553 | ||
| Pubmed | TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. | 8.69e-06 | 2 | 103 | 2 | 25940397 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 21993562 | ||
| Pubmed | Multiple variants of TERT and CLPTM1L constitute risk factors for lung adenocarcinoma. | 8.69e-06 | 2 | 103 | 2 | 22370939 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 23555636 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24615621 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 23908149 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 22893025 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 19369581 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 22134622 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 29450669 | ||
| Pubmed | Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells. | 8.69e-06 | 2 | 103 | 2 | 12217958 | |
| Pubmed | Polymorphisms of TERT and CLPTM1L and the risk of hepatocellular carcinoma in Chinese males. | 8.69e-06 | 2 | 103 | 2 | 25339005 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 23359026 | ||
| Pubmed | Fine mapping of chromosome 5p15.33 identifies novel lung cancer susceptibility loci in Han Chinese. | 8.69e-06 | 2 | 103 | 2 | 28335076 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 23433592 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 25027329 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 11727199 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 15190070 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 9828128 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 11677057 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 18978790 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 27436580 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 17145779 | ||
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 5.19e-05 | 4 | 103 | 2 | 10225957 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 12925573 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 11846405 | ||
| Pubmed | The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms. | 5.19e-05 | 4 | 103 | 2 | 37224017 | |
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 5.19e-05 | 4 | 103 | 2 | 12000766 | |
| Pubmed | Developmental expression profiles of Celsr (Flamingo) genes in the mouse. | 5.19e-05 | 4 | 103 | 2 | 11850187 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 21081471 | ||
| Pubmed | Inherited genetic variants associated with occurrence of multiple primary melanoma. | 5.19e-05 | 4 | 103 | 2 | 25837821 | |
| Pubmed | 5.41e-05 | 69 | 103 | 4 | 32238831 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SEL1L ATP9A ITPR1 SEMA3A GSTM3 CLPTM1L PCYOX1L SNX14 RINT1 CELSR1 NF1 CELSR3 TENM3 | 5.60e-05 | 1201 | 103 | 13 | 35696571 |
| Pubmed | Genome-wide association study identifies multiple loci associated with bladder cancer risk. | 6.24e-05 | 26 | 103 | 3 | 24163127 | |
| Pubmed | Gene expression in the developing mouse retina by EST sequencing and microarray analysis. | 6.71e-05 | 142 | 103 | 5 | 11812828 | |
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 19955392 | ||
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 8640223 | ||
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 20101243 | ||
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 21617256 | ||
| Pubmed | DNA damage activates p53 through a phosphorylation-acetylation cascade. | 8.64e-05 | 5 | 103 | 2 | 9744860 | |
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 9.19e-05 | 79 | 103 | 4 | 12679517 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CLTCL1 UBE3B TMC6 REV3L PCNX2 FOCAD CELSR1 PNPLA6 CELSR3 PDCD11 PRKDC TRAPPC9 | 1.07e-04 | 1105 | 103 | 12 | 35748872 |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 1.29e-04 | 33 | 103 | 3 | 25713288 | |
| Pubmed | Dystroglycan is a scaffold for extracellular axon guidance decisions. | 1.29e-04 | 6 | 103 | 2 | 30758284 | |
| Pubmed | 1.29e-04 | 6 | 103 | 2 | 19836008 | ||
| Pubmed | Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. | 1.29e-04 | 6 | 103 | 2 | 20543847 | |
| Pubmed | 1.31e-04 | 504 | 103 | 8 | 34432599 | ||
| Pubmed | ATP7A CLTCL1 CDS2 ITPR1 ORC2 CLPTM1L PCYOX1L NF1 PNPLA6 SCD PEX2 PRKDC | 1.79e-04 | 1168 | 103 | 12 | 19946888 | |
| Pubmed | Early embryonic expression patterns of the mouse Flamingo and Prickle orthologues. | 1.81e-04 | 7 | 103 | 2 | 17937400 | |
| Pubmed | 1.81e-04 | 7 | 103 | 2 | 10625539 | ||
| Pubmed | 1.81e-04 | 7 | 103 | 2 | 18454193 | ||
| Pubmed | 1.81e-04 | 7 | 103 | 2 | 12915301 | ||
| Pubmed | Genetic correction of PSA values using sequence variants associated with PSA levels. | 1.81e-04 | 7 | 103 | 2 | 21160077 | |
| Pubmed | Control of TurboID-dependent biotinylation intensity in proximity ligation screens. | 2.29e-04 | 100 | 103 | 4 | 36966971 | |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 2.38e-04 | 186 | 103 | 5 | 33637726 | |
| Pubmed | New common variants affecting susceptibility to basal cell carcinoma. | 2.40e-04 | 8 | 103 | 2 | 19578363 | |
| Pubmed | 2.40e-04 | 8 | 103 | 2 | 20810650 | ||
| Pubmed | 2.40e-04 | 8 | 103 | 2 | 10331952 | ||
| Pubmed | 3.08e-04 | 9 | 103 | 2 | 19654303 | ||
| Pubmed | Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human. | 3.85e-04 | 10 | 103 | 2 | 9736772 | |
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 3.85e-04 | 10 | 103 | 2 | 18160036 | |
| Pubmed | A role of DNA-PK for the metabolic gene regulation in response to insulin. | 3.85e-04 | 10 | 103 | 2 | 19303849 | |
| Pubmed | 3.85e-04 | 10 | 103 | 2 | 38713721 | ||
| Pubmed | ATP7A UBXN8 MTMR1 ITPR1 WDR19 GSTM3 CLPTM1L CACTIN NAA35 RINT1 PNPLA6 SCD PDCD11 | 4.53e-04 | 1487 | 103 | 13 | 33957083 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 4.69e-04 | 11 | 103 | 2 | 20427287 | |
| Pubmed | A dual role for planar cell polarity genes in ciliated cells. | 4.69e-04 | 11 | 103 | 2 | 25024228 | |
| Pubmed | WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation. | 5.02e-04 | 52 | 103 | 3 | 30655611 | |
| Pubmed | 5.62e-04 | 12 | 103 | 2 | 11891983 | ||
| Pubmed | 5.62e-04 | 12 | 103 | 2 | 20631168 | ||
| Pubmed | Nolz1 expression is required in dopaminergic axon guidance and striatal innervation. | 5.92e-04 | 55 | 103 | 3 | 32561725 | |
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 6.57e-04 | 57 | 103 | 3 | 21886157 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 7.27e-04 | 499 | 103 | 7 | 22810586 | |
| Interaction | HCST interactions | 6.66e-06 | 205 | 97 | 8 | int:HCST | |
| Interaction | CX3CL1 interactions | 2.36e-05 | 71 | 97 | 5 | int:CX3CL1 | |
| Interaction | HS3ST4 interactions | 2.99e-05 | 13 | 97 | 3 | int:HS3ST4 | |
| Cytoband | 16p12.3 | 6.24e-05 | 34 | 103 | 3 | 16p12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 6.30e-04 | 172 | 103 | 4 | chr16p12 | |
| Cytoband | 6q22.1 | 1.95e-03 | 29 | 103 | 2 | 6q22.1 | |
| Cytoband | 5q34 | 2.37e-03 | 32 | 103 | 2 | 5q34 | |
| Cytoband | 5p15.33 | 2.37e-03 | 32 | 103 | 2 | 5p15.33 | |
| Cytoband | 10q26.13 | 3.32e-03 | 38 | 103 | 2 | 10q26.13 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 3.93e-05 | 3 | 66 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 3.93e-05 | 3 | 66 | 2 | 1189 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 1.34e-03 | 15 | 66 | 2 | 903 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.87e-06 | 97 | 95 | 6 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_1000 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 3.44e-06 | 176 | 103 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.66e-06 | 192 | 103 | 6 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.15e-06 | 200 | 103 | 6 | a9b87accdaa6956116ab82427e1330e8f007ef94 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.47e-06 | 119 | 103 | 5 | e868453c02dcf0e07821886b81ca739887d43c67 | |
| Disease | sphingolipidosis (implicated_via_orthology) | 3.27e-05 | 3 | 98 | 2 | DOID:1927 (implicated_via_orthology) | |
| Disease | hypokalemia (biomarker_via_orthology) | 3.27e-05 | 3 | 98 | 2 | DOID:4500 (biomarker_via_orthology) | |
| Disease | head and neck carcinoma, lung cancer | 6.52e-05 | 4 | 98 | 2 | MONDO_0002038, MONDO_0008903 | |
| Disease | gallbladder carcinoma (is_implicated_in) | 1.08e-04 | 5 | 98 | 2 | DOID:4948 (is_implicated_in) | |
| Disease | Uterine leiomyoma | 2.45e-04 | 91 | 98 | 4 | HP_0000131 | |
| Disease | Lymphoid leukemia | 3.02e-04 | 8 | 98 | 2 | C0023448 | |
| Disease | Inherited neuropathies | 3.21e-04 | 40 | 98 | 3 | C0598589 | |
| Disease | response to simvastatin, myopathy | 3.46e-04 | 41 | 98 | 3 | EFO_0004145, GO_1903491 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 3.87e-04 | 9 | 98 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (is_marker_for) | 5.86e-04 | 49 | 98 | 3 | DOID:9119 (is_marker_for) | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 9.68e-04 | 14 | 98 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | Moyamoya Disease | 1.44e-03 | 17 | 98 | 2 | C0026654 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 1.61e-03 | 18 | 98 | 2 | EFO_1000649, HP_0000131 | |
| Disease | Antihypertensive use measurement | 1.94e-03 | 265 | 98 | 5 | EFO_0009927 | |
| Disease | electroencephalogram measurement | 1.94e-03 | 74 | 98 | 3 | EFO_0004357 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.94e-03 | 74 | 98 | 3 | DOID:3748 (is_marker_for) | |
| Disease | non-small cell lung carcinoma | 2.02e-03 | 75 | 98 | 3 | EFO_0003060 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 2.20e-03 | 21 | 98 | 2 | EFO_0004286, EFO_0004792 | |
| Disease | disease | 2.20e-03 | 21 | 98 | 2 | EFO_0000408 | |
| Disease | Lung diseases | 2.26e-03 | 78 | 98 | 3 | C0024115 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 2.64e-03 | 23 | 98 | 2 | EFO_0004286, EFO_0004791 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 2.87e-03 | 24 | 98 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 2.87e-03 | 24 | 98 | 2 | DOID:3907 (is_implicated_in) | |
| Disease | Periodontal Pocket | 3.12e-03 | 25 | 98 | 2 | EFO_1001393 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALLHWALHVYLGQEM | 336 | Q86VI1 | |
| QHLWYREQPILFLMD | 1156 | Q9HCE0 | |
| FFWMLAQALVLAHQL | 856 | Q8IZF5 | |
| WHTVMLYRDGLNGLL | 471 | Q63HQ2 | |
| LLIWYGVDVMARDAH | 506 | Q8TF27 | |
| MGILFTRIWRLFNHQ | 1 | Q9Y689 | |
| TLVIYVARLFWHMDQ | 111 | P41238 | |
| MGVFLREHLNYWYSL | 481 | P45844 | |
| RLQFYMFGWTHVTLL | 191 | O95674 | |
| WMHYDGLRNVNLILL | 276 | Q4W4Y0 | |
| VIHFLAWFLENMAVL | 3611 | Q86UQ4 | |
| FAWTLVESLHVYRML | 2546 | Q9NYQ6 | |
| MTDLVRYTRQGLHWL | 1141 | Q9UHB7 | |
| MLFVFIALGRWLEHI | 786 | Q04656 | |
| GTHWLEYIRMLLAGA | 406 | Q13613 | |
| VHYLLTLWQRMVASV | 376 | Q9H2T7 | |
| LTGARQYWLEGMLRH | 266 | Q68EN5 | |
| ILINIDYMLKALWHG | 146 | Q7Z5J8 | |
| VVNLMLAVGWYTAVH | 281 | Q96K12 | |
| RLLTHWEQMDYGLQF | 81 | Q53FV1 | |
| FVLWGCLHVYQRMID | 551 | Q8IY17 | |
| NAIRIGMYVLHLESW | 246 | Q9Y278 | |
| ELAKMFLNRINYWHL | 246 | Q92831 | |
| LLQGVFRVYHCNWLM | 1521 | Q14643 | |
| FTMLRAQYWFVAVPH | 996 | P54707 | |
| GIWYRSERNLQAHLM | 256 | Q8WW38 | |
| VQEQMGCLLHYRIYW | 546 | Q99665 | |
| DQYMLWFLLRHVTQR | 576 | P0C7V8 | |
| AHLVLSFLTMGYVWQ | 96 | Q6ZQW0 | |
| RDAALMVAYTWLHAL | 121 | Q8NDV2 | |
| WHYIERDLAMFNINI | 1566 | A6NKB5 | |
| HYGISFLRLQMWVEE | 136 | Q8NBM8 | |
| MNRELLWHGFAEFLI | 191 | P28328 | |
| MTGLYELVWRVLHAL | 1 | Q96E22 | |
| SMVLGYWDIRGLAHA | 6 | P21266 | |
| LVMVALQHFAGRWYL | 316 | O75110 | |
| LNLLHSYMNVTWIRI | 431 | Q8TE49 | |
| YVWRAVMACLVHRGL | 11 | Q8N2Q7 | |
| ILMGSRHYSNAIDIW | 311 | Q9UBE8 | |
| QMAITIWVIGFFHAL | 141 | P58182 | |
| LIWIDHRLQTPMYFF | 46 | Q8NGM8 | |
| RYTVLMNVHFWGLLI | 131 | Q8NGA0 | |
| RYVGDMLAWLHQATA | 306 | Q9Y2V7 | |
| IWVMAISQHQFYLDR | 346 | Q9Y2L6 | |
| NYIVRLGHLVSWMGE | 171 | Q16134 | |
| LQLMILQVLHLYWGY | 306 | Q8IU89 | |
| GWMQLVILIYHISGA | 436 | Q96PB1 | |
| GWIIRYLHANGASMF | 76 | P00156 | |
| LHMYQLEGLNWLRFS | 736 | Q12873 | |
| QELLGHAWMNYTAIL | 131 | P0DJR0 | |
| EIALLHRYQSQMLGW | 176 | Q5JW98 | |
| HRYQSQMLGWILITL | 181 | Q5JW98 | |
| AWVYYHMGRLSDVQI | 101 | P09913 | |
| GNRAVMALVYIWLHS | 141 | Q8N6U8 | |
| YWESLLQQLRAHMAR | 436 | Q8WUQ7 | |
| RVYLHLRQTWLAFMI | 306 | Q8IWA5 | |
| WAPRIIMILYHLYGA | 241 | Q6DWJ6 | |
| TFAWLFVQGLHLYRM | 2616 | Q9NYQ7 | |
| RRWFYLHLGCMMLIN | 6 | A0A1B0GVD1 | |
| YRVLLGHTLILMFIW | 301 | Q8IZD6 | |
| QAWLAYMNRAYHAIL | 891 | Q5VW36 | |
| LAWMILHSLYQARIV | 1616 | Q5VW36 | |
| IGWIIHAMEYELQIR | 876 | Q93100 | |
| LERLYLQMWEHYAAG | 1016 | O15294 | |
| WMLQLHLGFNIVLYG | 301 | Q13416 | |
| LRRAIWNYIHCMFGI | 401 | Q9Y6P5 | |
| WLDLMILRYAHMVNG | 341 | Q8N142 | |
| YAFGLVQLLCHWLAM | 311 | P49683 | |
| LIAHMVLGYRYWAGI | 291 | Q9UBV2 | |
| WLGVLLQQHMYVLRR | 1966 | Q96Q15 | |
| LWYLHKIGALRMQLD | 331 | Q92185 | |
| LAYFIAMHLLGLNWQ | 391 | Q9NT68 | |
| ALGMWIPLYLHRAQV | 331 | Q8IVW8 | |
| GLYHLAVGMNNRAWF | 396 | Q8NEZ3 | |
| VWYRDFMQLINHPNL | 701 | Q14563 | |
| WRFLTYMFMHVGLEQ | 246 | O75783 | |
| INHFWGVSSIYRMIL | 311 | Q08AH1 | |
| LGRLRFWIHMQDAVY | 246 | Q96KA5 | |
| AWRHNLVDLAMPYFI | 1586 | P53675 | |
| LWLQYMAFHLQATEI | 1621 | Q14690 | |
| ASMRHLELWVNYYIR | 526 | Q13496 | |
| ACLGTWVLYHNLRIM | 486 | Q5VZE5 | |
| WVLYHNLRIMIQYLL | 491 | Q5VZE5 | |
| IQMHSWGYLLQRAAA | 2406 | O60673 | |
| LLNYMNWFIIAGVLL | 56 | Q6ZMD2 | |
| YLAQVLMWIGNHTEF | 336 | Q6NUQ1 | |
| NRYIHILMIFWSFVA | 46 | Q9Y5W7 | |
| RHGRSYNLVTLLQMW | 76 | Q8N4F7 | |
| LFDSRHLLYQLLWNM | 1246 | P21359 | |
| DYMEFRLWIGLHSAV | 601 | Q9BY07 | |
| SYFIAMHLFGLNWQL | 326 | Q9P273 | |
| YVWRNIILMSLLHLG | 71 | O00767 | |
| MFWYRQDLGHGLRLI | 51 | A0A0K0K1A3 | |
| DVVRHWQDLGYMILY | 766 | Q9BZ71 | |
| RQLYEPLVMQLIHWF | 981 | P78527 | |
| MQGWFHFLQDRYIVV | 106 | Q9UBD6 | |
| IWNTFFHGRYLILLM | 441 | Q9HBG4 | |
| FQSVHGWLMVLYERD | 591 | Q7Z3V4 | |
| WAAVQMRLLHELVYA | 456 | Q96Q05 | |
| LLLHMWVALFYSNQN | 791 | Q5VWN6 | |
| LPWVHRYLMENTFFV | 711 | Q7Z403 | |
| MFWYRQDLGHGLRLI | 51 | A0A0K0K1G8 | |
| GMFYVITWQTHLLAI | 821 | Q15849 | |
| WETFVALYHVLRMLQ | 2726 | Q6ZQQ6 | |
| HQGRLYWSDLQAMFL | 131 | Q9UP52 | |
| VLFDWMTRIGYHISL | 216 | O00124 | |
| MILVNALYFKGIWEH | 181 | P48595 | |
| YWQMRPLFLELLGNH | 386 | O14746 | |
| HWLMSVYVVELLRSF | 546 | O14746 | |
| AYIQDHMLIASLWRV | 1001 | Q9P2D8 |